Ending tuberculosis with innovation in diagnosis, treatment, and prevention
Tuberculosis (TB) can be cured, yet each year, nearly 1.5 million people die from the disease. Worldwide, it remains a leading killer of women and a devastating threat to people living with HIV. In addition, resistance to lifesaving drugs is increasing, making diagnosis, treatment, and prevention more urgent than ever.
At PATH, we work hand-in-hand with governments and partners to effectively and sustainably combat TB, particularly in countries with a high burden of the disease.
A spectrum of strategies
To succeed, we use a combination of strategies essential to treating and curing people living with TB and HIV/TB co-infection. We develop, introduce, and scale approaches and technologies to improve diagnosis, treatment, and support. We strengthen health systems and build public- and private-sector collaborations to support care. And we mobilize communities to protect themselves by increasing case detection, strengthening treatment and adherence, and reducing stigma.
We’re also taking on the dangerous overlap between TB and other diseases, such as HIV and diabetes. By integrating diagnosis and treatment of TB with other health services, we’re improving outcomes, reducing transmission, and saving more lives.
We believe that concerted and collective efforts will lead to a world free of TB. With our partners around the world, we’re rising to the challenge—and moving closer to our goal.
Photo: PATH/Gabe Bienczycki.